Dataset from A Phase 1, Open-label Study to Evaluate the Pharmacokinetics, Safety and Tolerability, and Pharmacodynamics of a Single Dose of Lanadelumab Administered Subcutaneously in Healthy Adult Japanese Subjects and Matched Healthy Adult Caucasian Subjects
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009404
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the pharmacokinetics (PK), safety and tolerability
and pharmacodynamics (PD) of lanadelumab in healthy adult Japanese subjects and matched
non-Hispanic healthy adult Caucasian subjects.
创建时间：
2024-11-26
